156 related articles for article (PubMed ID: 15547713)
21. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
Lam LT; Davis RE; Pierce J; Hepperle M; Xu Y; Hottelet M; Nong Y; Wen D; Adams J; Dang L; Staudt LM
Clin Cancer Res; 2005 Jan; 11(1):28-40. PubMed ID: 15671525
[TBL] [Abstract][Full Text] [Related]
22. Differential requirement for the stress-activated protein kinase/c-Jun NH(2)-terminal kinase in RNAdamage-induced apoptosis in primary and in immortalized fibroblasts.
Iordanov MS; Wong J; Newton DL; Rybak SM; Bright RK; Flavell RA; Davis RJ; Magun BE
Mol Cell Biol Res Commun; 2000 Aug; 4(2):122-8. PubMed ID: 11170843
[TBL] [Abstract][Full Text] [Related]
23. Combined effects of onconase and IFN-beta on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cells.
Tsai SY; Hsieh TC; Ardelt B; Darzynkiewicz Z; Wu JM
Int J Oncol; 2002 May; 20(5):891-6. PubMed ID: 11956580
[TBL] [Abstract][Full Text] [Related]
24. Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.
Hironaka N; Mochida K; Mori N; Maeda M; Yamamoto N; Yamaoka S
Neoplasia; 2004; 6(3):266-78. PubMed ID: 15153339
[TBL] [Abstract][Full Text] [Related]
25. MALT-1 as a novel therapeutic target for adult T-cell leukemia.
Ishikawa C; Mori N
Eur J Haematol; 2020 Oct; 105(4):460-467. PubMed ID: 32574386
[TBL] [Abstract][Full Text] [Related]
26. Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.
Altomare DA; Rybak SM; Pei J; Maizel JV; Cheung M; Testa JR; Shogen K
BMC Cancer; 2010 Feb; 10():34. PubMed ID: 20137089
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
Benbijja M; Mellouk A; Bobé P
Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
[TBL] [Abstract][Full Text] [Related]
29. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
Majumdar S; Aggarwal BB
Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z
J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
Nishioka C; Ikezoe T; Yang J; Komatsu N; Bandobashi K; Taniguchi A; Kuwayama Y; Togitani K; Koeffler HP; Taguchi H
Leuk Res; 2008 Feb; 32(2):287-96. PubMed ID: 17644177
[TBL] [Abstract][Full Text] [Related]
32. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.
Lin JJ; Newton DL; Mikulski SM; Kung HF; Youle RJ; Rybak SM
Biochem Biophys Res Commun; 1994 Oct; 204(1):156-62. PubMed ID: 7945354
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells.
Srivastava SK; Singh SV
Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.
Li L; Aggarwal BB; Shishodia S; Abbruzzese J; Kurzrock R
Cancer; 2004 Nov; 101(10):2351-62. PubMed ID: 15476283
[TBL] [Abstract][Full Text] [Related]
39. Interferon enhances the activity of the anticancer ribonuclease, onconase.
Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
